BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 8350967)

  • 41. Burkitt's lymphoma in a 45-year-old Nigerian woman.
    Lawal OO; Ojo OS; Durosinmi MA
    Trop Geogr Med; 1990 Jul; 42(3):294-7. PubMed ID: 2293442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aggressive chemotherapy in the treatment of Burkitt's and non-Burkitt's undifferentiated lymphoma.
    Mazza JJ; Hines JD; Andersen JW; Neiman RS; Mann R; Oken MM; O'Connell MJ
    Leuk Lymphoma; 1995 Jul; 18(3-4):289-96. PubMed ID: 8535195
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Severe central nervous adverse effect of intrathecal chemotherapy in a 16-yr-old patient with Burkitt's type lymphoma.
    Geissler RG; Bergmann L; Hacker H; Knupp B; Walker B; Hoelzer D
    Eur J Haematol; 1997 Apr; 58(4):286-8. PubMed ID: 9186541
    [No Abstract]   [Full Text] [Related]  

  • 44. The Cameroon 2008 Burkitt lymphoma protocol: improved event-free survival with treatment adapted to disease stage and the response to induction therapy.
    Hesseling PB; Njume E; Kouya F; Katayi T; Wharin P; Tamannai M; Achu P; Kidd M; McCormick P
    Pediatr Hematol Oncol; 2012 Mar; 29(2):119-29. PubMed ID: 22376015
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study.
    Rigacci L; Carrai V; Nassi L; Alterini R; Longo G; Bernardi F; Bosi A
    Cancer; 2005 Mar; 103(5):970-7. PubMed ID: 15666323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Long-term remission of a case of Burkitt's lymphoma accompanied by cardiac tamponade treated by surgical resection and intensive chemotherapy].
    Ikematsu W; Aso T; Hirota Y; Okamura H; Matsumoto I; Ayabe S; Matsuzaka T; Iwashita A
    Rinsho Ketsueki; 1990 Oct; 31(10):1731-5. PubMed ID: 2255064
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effective multi-agent chemotherapy for advanced abdominal lymphoma and FAB L3 leukemia of childhood.
    Toogood IR; Tiedemann K; Stevens M; Smith PJ
    Med Pediatr Oncol; 1993; 21(2):103-10. PubMed ID: 8433675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of primary mediastinal large B-cell lymphomas].
    Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
    Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
    Wang M; Fayad L; Cabanillas F; Hagemeister F; McLaughlin P; Rodriguez MA; Kwak LW; Zhou Y; Kantarjian H; Romaguera J
    Cancer; 2008 Nov; 113(10):2734-41. PubMed ID: 18973182
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Curability of Burkitt's lymphoma with high-dose cyclophosphamide-high-dose methotrexate therapy and intrathecal chemoprophylaxis.
    Sullivan MP; Ramirez I
    J Clin Oncol; 1985 May; 3(5):627-36. PubMed ID: 3839010
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intensive chemotherapy in patients with generalized Burkitt's lymphoma.
    Ziegler JL; Bluming AZ; Magrath IT; Carbone PP
    Int J Cancer; 1972 Sep; 10(2):254-61. PubMed ID: 4574467
    [No Abstract]   [Full Text] [Related]  

  • 53. [Chemotherapy of nonendemic Burkitt's lymphoma].
    Kath R; Höffken K; Günzel K; Nowrousian MR; Donhuijsen K; Anders CU; Sack H; Schmidt CG
    Dtsch Med Wochenschr; 1990 Aug; 115(33):1219-26. PubMed ID: 2387214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Burkitt's lymphoma--a case report].
    Obeid L; Schär B; Heitzmann F; Bargetzi M
    Praxis (Bern 1994); 1999 Sep; 88(36):1444-8. PubMed ID: 10500420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
    Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
    Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high-risk non-Hodgkin's lymphoma.
    Schenkein DP; Roitman D; Miller KB; Morelli J; Stadtmauer E; Pecora AL; Cassileth P; Fernandez H; Cooper BW; Kutteh L; Lazarus HM
    Biol Blood Marrow Transplant; 1997 Oct; 3(4):210-6. PubMed ID: 9360783
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Burkitt's lymphoma and tumor lysis syndrome].
    Gómez Campderá FJ; López Gómez JM; Delgado J; Ramos M; Morales JL; Lugue A; Gómez Campderá J
    Rev Clin Esp; 1985 Mar; 176(4):210-1. PubMed ID: 4001471
    [No Abstract]   [Full Text] [Related]  

  • 58. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
    Longo DL; Duffey PL; Gribben JG; Jaffe ES; Curti BD; Gause BL; Janik JE; Braman VM; Esseltine D; Wilson WH; Kaufman D; Wittes RE; Nadler LM; Urba WJ
    Cancer J; 2000; 6(3):146-50. PubMed ID: 10882329
    [TBL] [Abstract][Full Text] [Related]  

  • 59. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
    Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
    J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclophosphamide, oncovin, methotrexate, leucovorin, cytosine arabinoside): a 10-year experience in a single institution.
    Gaynor ER; Ultmann JE; Golomb HM; Sweet DL
    J Clin Oncol; 1985 Dec; 3(12):1596-604. PubMed ID: 3877790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.